[go: up one dir, main page]

NL7512678A - Werkwijze voor het isoleren en karakteriseren van een bij menselijke kanker betrokken eiwit. - Google Patents

Werkwijze voor het isoleren en karakteriseren van een bij menselijke kanker betrokken eiwit.

Info

Publication number
NL7512678A
NL7512678A NL7512678A NL7512678A NL7512678A NL 7512678 A NL7512678 A NL 7512678A NL 7512678 A NL7512678 A NL 7512678A NL 7512678 A NL7512678 A NL 7512678A NL 7512678 A NL7512678 A NL 7512678A
Authority
NL
Netherlands
Prior art keywords
characterizing
insulating
human cancer
protein involved
protein
Prior art date
Application number
NL7512678A
Other languages
English (en)
Original Assignee
Osther Kurt Baekgaard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK564774A external-priority patent/DK564774A/da
Priority claimed from DK70875A external-priority patent/DK70875A/da
Priority claimed from DK157475A external-priority patent/DK157475A/da
Application filed by Osther Kurt Baekgaard filed Critical Osther Kurt Baekgaard
Publication of NL7512678A publication Critical patent/NL7512678A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/817—Entrapped within the carrier, e.g. gel, hollow fibre
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL7512678A 1974-10-30 1975-10-29 Werkwijze voor het isoleren en karakteriseren van een bij menselijke kanker betrokken eiwit. NL7512678A (nl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK564774A DK564774A (da) 1974-10-30 1974-10-30 Opfindelsen angar imunglobuliner rettet mod maskerende proteiner pa humane cancercellemembraner
DK70875A DK70875A (da) 1975-02-25 1975-02-25 Demaskering af cancer cellemembraner, ved hjelp af specifikke antistoffer. immunoglobuliner rettet mod maskerende proteiner pa humane cancercelle membraner
DK157475A DK157475A (da) 1975-04-11 1975-04-11 Fremgangsmade til fremstilling af et cancerassocieret protein
DK386475 1975-08-27
DK450375 1975-10-06

Publications (1)

Publication Number Publication Date
NL7512678A true NL7512678A (nl) 1976-05-04

Family

ID=27512806

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7512678A NL7512678A (nl) 1974-10-30 1975-10-29 Werkwijze voor het isoleren en karakteriseren van een bij menselijke kanker betrokken eiwit.

Country Status (14)

Country Link
US (1) US4132769A (nl)
JP (1) JPS5191322A (nl)
AU (1) AU518663B2 (nl)
BE (1) BE835020A (nl)
CA (1) CA1083037A (nl)
CH (1) CH635242A5 (nl)
DE (1) DE2548636A1 (nl)
FI (1) FI56117C (nl)
FR (1) FR2289205A1 (nl)
GB (1) GB1531762A (nl)
NL (1) NL7512678A (nl)
NO (1) NO753638L (nl)
NZ (1) NZ179095A (nl)
SE (1) SE7512192L (nl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
JPS548714A (en) * 1977-06-16 1979-01-23 Saikin Kagaku Kenkiyuushiyo Kk Production of specific antiserum
US4620972A (en) * 1978-02-27 1986-11-04 Lakatos George C Method of inhibiting the growth of malignant tumor cells
US6410697B1 (en) * 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4447545A (en) * 1980-11-03 1984-05-08 New England Deaconess Hospital Bladder cancer detection
US4525459A (en) * 1982-01-27 1985-06-25 University Of Miami New purified glycoproteins and use in diagnosing infectious mononucleosis
US4489167A (en) * 1981-06-02 1984-12-18 Baxter Travenol Laboratories, Inc. Methods and compositions for cancer detection
US6419927B1 (en) 1981-09-08 2002-07-16 Anthony Cerami Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages
US6309640B1 (en) 1981-09-08 2001-10-30 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer
AU569467B2 (en) * 1982-04-07 1988-02-04 Baylor College Of Medicine Immunoglobulin based cancer treating pharmaceutical compositions
IE820942L (en) * 1982-04-21 1983-10-21 Bartos Patent Dev Holding Determining in-viro effectiveness of cytostatic agents
JPS5990052A (ja) * 1982-11-16 1984-05-24 Katsu Taniguchi モノクロ−ナル特異抗体を用いたメラノ−マ診断薬
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
JPH0639385B2 (ja) * 1983-04-18 1994-05-25 精次 高山 新規免疫抗癌剤及びその製法
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors
US5665216A (en) * 1986-10-21 1997-09-09 Northeastern University Capillary column for high performance electrophoretic separation and detection of SDS proteins and system and using the same
US4997537A (en) * 1986-10-21 1991-03-05 Northeastern University High performance microcapillary gel electrophoresis
US5171666A (en) * 1988-04-22 1992-12-15 Eli Lilly And Company Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas
US5008183A (en) * 1988-05-10 1991-04-16 Bio-Research Laboratories, Inc. Assay system for detecting antibody and a method of producing non-human immune antibody
US5286852A (en) * 1988-07-06 1994-02-15 Verigen, Inc. Antibodies specific towards HIV-1 gp 48
US5658569A (en) * 1988-07-06 1997-08-19 Verigen, Inc. Anti-HIV-1 neutralizing antibodies
US5529776A (en) * 1988-07-06 1996-06-25 Verigen Inc. Anti-HIV-1 neutralizing antibodies
US5179198A (en) * 1988-07-11 1993-01-12 Hidechika Okada Glycoprotein and gene coding therefor
US5179008A (en) * 1989-02-09 1993-01-12 Wisconsin Alumni Research Foundation Hybridoma and monoclonal antibody to FHAP
US5001052A (en) * 1989-02-09 1991-03-19 Wisconsin Alumni Research Foundation Immunoassay for FHAP and antibody useful therewith
WO1994003470A1 (en) * 1992-08-10 1994-02-17 Davies Richard J Method and apparatus for screening and diagnosing for cancers
US6218171B1 (en) * 1998-06-18 2001-04-17 Battelle Memorial Institute Microbial methods of reducing technetium
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
US7420028B2 (en) * 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7452963B2 (en) * 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore
KR100906102B1 (ko) * 2001-03-27 2009-07-07 사무엘 보고치 레플리킨 펩타이드 및 그의 이용
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7774144B2 (en) * 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US6627607B2 (en) * 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
ES2541351T3 (es) 2002-02-25 2015-07-17 Vaxiion Therapeutics, Llc Composiciones de minicélulas y procedimientos
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US20050059101A1 (en) * 2003-09-10 2005-03-17 Gordon Ringold Bivalent targeting of cell surfaces
RU2364404C2 (ru) * 2003-12-18 2009-08-20 Оуэн Холдинг Лтд. Биологически активная сыворотка крови, способы ее получения и ее применение
US9254315B2 (en) * 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US8135595B2 (en) * 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
AU2007319669A1 (en) * 2006-05-30 2008-05-22 Elenore S. Bogoch Replikin peptides and uses thereof
KR20100006574A (ko) * 2007-05-30 2010-01-19 사무엘 보고치 수산 양식되는 무척추동물의 병원체 감염에 대항하는 합성 레플리킨 펩티드
US20090269367A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US20100144589A1 (en) * 2008-08-08 2010-06-10 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
US9320784B2 (en) 2009-08-07 2016-04-26 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
JP5651176B2 (ja) * 2009-08-20 2015-01-07 スペクトロセンス リミテッド ガスクロマトグラフ分析方法およびシステム
WO2016081889A1 (en) 2014-11-21 2016-05-26 Kurt Baekgaard Osther Recombinant c1 esterase inhibitor and use thereof
EP3411715B1 (en) 2016-02-05 2019-11-20 Dana Genetic A/S Method for diagnosing and treating cancer using antibodies that bind to c1 inactivator, c reactive protein and/or complement component c4

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2165370A (en) * 1936-10-06 1939-07-11 Lakeland Foundation Carcinoma antigen
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
IL42594A (en) * 1972-07-10 1976-08-31 Bjoerklund K Cancer associated polypeptide antigen,its preparation,its detection and immunizing compositions containing it
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
ZA723264B (en) * 1972-10-13 1974-08-28 H Van Til Improvements in toys
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies

Also Published As

Publication number Publication date
BE835020A (fr) 1976-04-29
CA1083037A (en) 1980-08-05
US4132769A (en) 1979-01-02
JPS5191322A (nl) 1976-08-10
AU518663B2 (en) 1981-10-15
FI753025A (nl) 1976-05-01
AU8609475A (en) 1977-05-05
NO753638L (nl) 1976-07-16
FR2289205B1 (nl) 1981-11-13
GB1531762A (en) 1978-11-08
SE7512192L (sv) 1976-06-16
FR2289205A1 (fr) 1976-05-28
FI56117B (fi) 1979-08-31
DE2548636A1 (de) 1976-05-13
NZ179095A (en) 1978-11-13
FI56117C (fi) 1979-12-10
CH635242A5 (fr) 1983-03-31

Similar Documents

Publication Publication Date Title
NL7512678A (nl) Werkwijze voor het isoleren en karakteriseren van een bij menselijke kanker betrokken eiwit.
NL7509188A (nl) Werkwijze voor het bereiden van een preparaat voor het behandelen en opmaken van haar.
NL7605657A (nl) Helicopterrotor en werkwijze voor het ver- vaardigen van een constructiedeel hiervan.
NL7506837A (nl) Werkwijze en inrichting voor het watergolven en behandelen van haar.
NL7502652A (nl) Werkwijze voor het behandelen van tabak, alsmede aldus verkregen produkt.
BE777309A (nl) Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen
NL7710418A (nl) Werkwijzen voor het bereiden en toepassen van peptiden.
NL7508804A (nl) Auto-kinderstoel en werkwijze voor het samenstel- len hiervan.
NL7501472A (nl) Werkwijze voor de bereiding van acrylonitril en ysator ten gebruike daarbij.
NL7405711A (nl) Behandelingswijze van vlees, meer in het bij- zonder hamvlees, en inrichting voor toepassing bij een dergelijke behandelingswijze.
NL7504461A (nl) Werkwijze voor het vervaardigen van een lens en lens vervaardigd volgens deze werkwijze.
NL7512917A (nl) Werkwijze voor het verbinden van foelies.
NL7714310A (nl) Werkwijze voor het met zuur behandelen van een ondergrondse formatie en zuurcompositie geschikt voor toepassing bij deze werkwijze.
NL7512339A (nl) Werkwijze voor het behandelen van het bij de kaasbereiding verkregen lactoserum.
NL7505886A (nl) Werkwijze voor het behandelen van een onder- materiaal.
NL7501919A (nl) Werkwijze en inrichting voor het vervaardigen van filterpropjes ten gebruike bij sigaretten en dergelijke voorwerpen.
NL7503020A (nl) Werkwijze en inrichting voor het vervaardigen van filterpropjes ten gebruike bij sigaretten en dergelijke voorwerpen.
NL164203B (nl) Werkwijze voor het bereiden van bevroren mensenbloed of een etythrocyten-bevattende fractie daarvan bij aanwezigheid van een cryofylacticum.
BE878834A (fr) Drager voor een transducent voor het uitzenden en/of ontvangen van ultrasone signalen in een bepaalde hoeksector
NL7514547A (nl) Werkwijze voor het verenigen van elementen in de warmte.
NL7509895A (nl) Werkwijze voor het analyseren van proteine.
NL7611331A (nl) Werkwijze voor het bereiden van snacks en aldus bereide snacks.
NL7504109A (nl) Werkwijze voor het winnen van het in de wortels en rizomen van helleborus-soorten voorkomende hoofdsapogenine.
NL7507603A (nl) N-gesubstitueerde derivaten van n-fosfonomethyl- glycine en werkwijzen voor hun bereiding en toe- passing.
NL7610461A (nl) Werkwijze voor het behandelen van elementen in een ruimte.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: A/S ALFRED BENZON

BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed